Skip to main content

Figure 4 .

Figure 4

: Kaplan-Meier survival plots for patients with Child's A and B liver disease randomised to receive sclerotherapy (INJ/AB) or octreotide (OCT/AB). The survival of patients with severe liver disease (Child's C) in either the sclerotherapy (INJ/C) or octreotide (OCT/C) group was plotted separately. Time zero indicates the commencement of therapy.